Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform
Authors
Crabb, S. J.Dempsey, L.
Soulis, E.
Hinsley, S.
Song, Yee Pei
Barber, J.
Frew, J.
Gale, J.
Faust, G.
Brock, S.
McGovern, U. B.
Parikh, O. A.
Enting, D.
Sundar, S.
Ratnayake, G.
Lees, K.
Hussain, S. A.
Powles, T. B.
Jones, R.
Tapper, W.
Affiliation
Southampton Experimental Cancer Medicine Centre, University of Southampton, SouthamptonIssue Date
2022
Metadata
Show full item recordCitation
Crabb SJ, Dempsey L, Soulis E, Hinsley S, Song YP, Barber J, et al. Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform. Annals of Oncology. 2022 Sep;33(7):S1348-S. PubMed PMID: WOS:000866211602322.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.07.1850Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.1850Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.07.1850